Jounce therapeutics, inc. (JNCE)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15
Revenue:
License and collaboration revenue—related party

147,872

65,201

71,644

37,197

0

Operating expenses:
Research and development

67,135

70,052

67,798

34,904

22,130

General and administrative

27,920

26,443

23,061

16,759

8,266

Total operating expenses

95,055

96,495

90,859

51,663

30,396

Operating loss

52,817

-31,294

-19,215

-14,466

-30,396

Other income, net

4,052

3,961

2,808

763

5

Other financing income, net

-

-

-

0

1,859

Total other income, net

-

-

-

763

1,864

Loss before provision for income taxes

56,869

-27,333

-16,407

-13,703

-28,532

Provision for income taxes

46

46

36

0

0

Net Income (Loss) Attributable to Parent

56,823

-27,379

-16,443

-13,703

-28,532

Accretion of convertible preferred stock to redemption value

-

-

-

0

1,011

Loss on extinguishment of convertible preferred stock

-

-

-

0

2,079

Net loss attributable to common stockholders

-

-

-17,237

-23,138

-37,503

Net income (loss) per share, basic (in dollars per share)

1.72

-0.84

-

-

-

Net income (loss) per share, diluted (in dollars per share)

1.66

-0.84

-

-

-

Net loss per share, basic and diluted (in dollars per share)

-

-

-0.57

-11.00

-23.13

Weighted-average common shares outstanding, basic (in shares)

33,080

32,567

-

-

-

Weighted-average common shares outstanding, diluted (in shares)

34,294

32,567

-

-

-

Weighted-average common shares outstanding, basic and diluted (in shares)

-

-

30,055

2,103

1,621

Comprehensive loss:
Comprehensive income (loss):
Net Income (Loss) Attributable to Parent

56,823

-27,379

-16,443

-13,703

-28,532

Other comprehensive income:
Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent

132

331

-

-

-

Comprehensive loss

56,955

-27,048

-

-

-

Series A Convertible Preferred Stock
Accrued dividends on convertible preferred stock

-

-

268

-

-

Series B Convertible Preferred Stock
Accrued dividends on convertible preferred stock

-

-

318

-

-

Series B-1 Convertible Preferred Stock
Accrued dividends on convertible preferred stock

-

-

208

-

-